Role of biosimilar pegfilgrastim in the treatment of febrile neutropenia: A Mini Review Review

cited authors

  • Shahab, Shania; Ahmad, S.

Publication Date

  • January 1, 2024

webpage

published in

category

keywords

  • Adverse events
  • Biosimilars
  • Chemotherapy-induced
  • Cost-effectiveness
  • Febrile neutropenia
  • GCSFs
  • Pegfilgrastim
  • Pharmacodynamic and pharmacokinetic profiles
  • Regulatory approvals
  • Savings
  • Therapeutics

start page

  • 7

end page

  • 15

volume

  • 61

issue

  • 1